Conveners
Biological Systems
- Nathan Cowieson (Australian Synchrotron)
-
Dr Karagiannis Tom (Baker IDI Heart and Diabetes Institute)20/11/2014, 13:30Biological SystemsOralPhototherapy is a well-established therapeutic strategy in dermatology, particularly for the treatment of psoriasis and cutaneous T-cell lymphoma. Treatment may either rely on the cytotoxic effect of light of a particular wavelength (e.g. UVB and narrowband UVB) or may require the use of a sensitizer (e.g. psoralens with UVA). We have developed iodinated DNA minor groove binding...Go to contribution page
-
Ms Donna Whelan (Monash University)20/11/2014, 14:00Biological SystemsOralSynchrotron Fourier transform infrared (SFTIR) spectroscopy provides the best available signal-to-noise which allows for fast, sensitive detection of the holistic biochemistry of single live cells. Recently developed super-resolution fluorescence microscopy (SRFM) techniques based on single molecule emissions can yield an order of magnitude improvement in spatial resolution in the imaging of...Go to contribution page
-
Prof. Anthony White (University of Melbourne)20/11/2014, 14:20Biological SystemsOralA hallmark of neurodegeneration is a failure of homeostatic mechanisms controlling the concentration and distribution of biometals. A major roadblock to understanding the impact of altered biometal homeostasis in neurodegenerative disease is the lack of specific and sensitive techniques capable of providing quantitative subcellular information on biometals in situ. Advances in X-ray...Go to contribution page
-
Dr Mark Tobin (Australian Synchrotron)20/11/2014, 14:40Biological SystemsOralDevelopments to enable infrared microspectroscopy to extend beyond the far field diffraction limit are being undertaken at several accelerator facilities worldwide. These include the CLIO Free Electron Laser (Paris, France), LNLS (Campinas, Brazil), and the ALS infrared beamline (Berkeley, USA). Without such developments, the spatial resolution in the mid-IR is typically 3 to 5 microns. Two...Go to contribution page